SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.
Carla ColomboGianfranco AlicandroValeria DaccóVanessa GaglianoLetizia Corinna MorlacchiRosaria CasciaroGiovanna PisiMichela FrancalanciRaffaele BadolatoElisabetta BignaminiBarbara MessoreMaria Cristina LucantoGiuseppina LeonettiMassimo MaschioMarco Cipollinull nullPublished in: PloS one (2021)
The course of SARS-CoV-2 in our patients was relatively favorable. However, COVID-19 should not be considered a mild disease in CF patients, particularly for those with severely impaired respiratory function and organ transplant.